Cabaletta Bio annual depreciation and amortization
2018
2019
2020
2021
2022
2023
2024
2025
Cabaletta Bio Depreciation & Amortization Growth & History (CABA)
Cabaletta Bio's depreciation and amortization was $1.6M for fiscal 2025.
View full Cabaletta Bio company overviewCabaletta Bio annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.6M | −$3.2M | −65.80% |
| 2024 | 2024-12-31 | $4.8M | $3.4M | +237.52% |
| 2023 | 2023-12-31 | $1.4M | $248,000 | +21.05% |
| 2022 | 2022-12-31 | $1.2M | $445,000 | +60.71% |
| 2021 | 2021-12-31 | $733,000 | $379,000 | +107.06% |
| 2020 | 2020-12-31 | $354,000 | $250,000 | +240.38% |
| 2019 | 2019-12-31 | $104,000 | $104,000 | — |
| 2018 | 2018-12-31 | $0 | — | — |
Cabaletta Bio quarterly depreciation and amortization
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $371,000 | −$97,000 | −20.73% |
| Q1 2026 | 2026-03-31 | $337,000 | −$148,000 | −30.52% |
| Q4 2025 | 2025-12-31 | $348,000 | — | — |
| Q3 2025 | 2025-09-30 | $345,000 | −$79,000 | −18.63% |
| Q2 2025 | 2025-06-30 | $468,000 | $42,000 | +9.86% |
| Q1 2025 | 2025-03-31 | $485,000 | $92,000 | +23.41% |
| Q3 2024 | 2024-09-30 | $424,000 | $69,000 | +19.44% |
| Q2 2024 | 2024-06-30 | $426,000 | $56,000 | +15.14% |
| Q1 2024 | 2024-03-31 | $393,000 | $28,000 | +7.67% |
| Q3 2023 | 2023-09-30 | $355,000 | −$8,000 | −2.20% |
| Q2 2023 | 2023-06-30 | $370,000 | $132,000 | +55.46% |
| Q1 2023 | 2023-03-31 | $365,000 | $146,000 | +66.67% |
| Q3 2022 | 2022-09-30 | $363,000 | $142,000 | +64.25% |
| Q2 2022 | 2022-06-30 | $238,000 | $76,000 | +46.91% |
| Q1 2022 | 2022-03-31 | $219,000 | $103,000 | +88.79% |
| Q3 2021 | 2021-09-30 | $221,000 | $131,000 | +145.56% |
| Q2 2021 | 2021-06-30 | $162,000 | $84,000 | +107.69% |
| Q1 2021 | 2021-03-31 | $116,000 | $40,000 | +52.63% |
| Q3 2020 | 2020-09-30 | $90,000 | $58,000 | +181.25% |
| Q2 2020 | 2020-06-30 | $78,000 | — | — |
| Q1 2020 | 2020-03-31 | $76,000 | — | — |
| Q3 2019 | 2019-09-30 | $32,000 | — | — |
Cabaletta Bio depreciation and amortization trends
Over the last five fiscal years, Cabaletta Bio's depreciation and amortization increased from $354,000 to $1.6M, a change of $1.3M. The latest reported quarter, Q2 2026, shows $371,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cabaletta Bio source filings ↗